While it has been shown that the Idylla EGFR test reduces the time to EGFR mutation result in NSCLC patients, there is yet to be a comparison of TTT between patients who receive Idylla EGFR testing and those who receive only NGS panel testing [27]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.